59 related articles for article (PubMed ID: 17170077)
1. Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting.
Houtenbos I; Westers TM; Dijkhuis A; de Gruijl TD; Ossenkoppele GJ; van de Loosdrecht AA
Clin Cancer Res; 2007 Jan; 13(1):307-15. PubMed ID: 17170077
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of acute and chronic myeloid leukemic blasts into the dendritic cell lineage: analysis of various differentiation-inducing signals.
Kharfan-Dabaja M; Ayala E; Lindner I; Cejas PJ; Bahlis NJ; Kolonias D; Carlson LM; Lee KP
Cancer Immunol Immunother; 2005 Jan; 54(1):25-36. PubMed ID: 15693136
[TBL] [Abstract][Full Text] [Related]
3. Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia.
Qin L; Dominguez D; Chen S; Fan J; Long A; Zhang M; Fang D; Zhang Y; Kuzel TM; Zhang B
Oncotarget; 2016 Sep; 7(38):61069-61080. PubMed ID: 27517629
[TBL] [Abstract][Full Text] [Related]
4. Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans.
Robin M; Schlageter MH; Chomienne C; Padua RA
Cancer Immunol Immunother; 2005 Oct; 54(10):933-43. PubMed ID: 15889256
[TBL] [Abstract][Full Text] [Related]
5. Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model.
Stroopinsky D; Liegel J; Bhasin M; Cheloni G; Thomas B; Bhasin S; Panchal R; Ghiasuddin H; Rahimian M; Nahas M; Orr S; Capelletti M; Torres D; Tacettin C; Weinstock M; Bisharat L; Morin A; Mahoney KM; Ebert B; Stone R; Kufe D; Freeman GJ; Rosenblatt J; Avigan D
Haematologica; 2021 May; 106(5):1330-1342. PubMed ID: 33538148
[TBL] [Abstract][Full Text] [Related]
6. Immunologic Targets in AML.
Ritz J
Blood Cancer Discov; 2023 Nov; 4(6):430-432. PubMed ID: 37847743
[TBL] [Abstract][Full Text] [Related]
7. CD8+ T-cell Differentiation and Dysfunction Inform Treatment Response in Acute Myeloid Leukemia.
Mazziotta F; Biavati L; Rimando JC; Rutella S; Borcherding N; Parbhoo S; Mukhopadhyay R; Knaus HA; Valent P; Hackl H; Borrello I; Blazar BR; Hatzi K; Gojo I; Luznik L
Blood; 2024 May; ():. PubMed ID: 38776511
[TBL] [Abstract][Full Text] [Related]
8. Immunotargeting of a recurrent AML-specific neoantigen.
Apavaloaei A; Perreault C
Nat Cancer; 2023 Oct; 4(10):1403-1405. PubMed ID: 37783806
[No Abstract] [Full Text] [Related]
9. Bamezai S, Pulikkottil AJ, Yadav T, et al. A noncanonical enzymatic function of PIWIL4 maintains genomic integrity and leukemic growth in AML. Blood. 2023;142(1):90-105.
Blood; 2024 Jan; 143(2):184. PubMed ID: 38206638
[No Abstract] [Full Text] [Related]
10. Expression of 4-1BB and its ligand on blasts correlates with prognosis of patients with AML.
Schmohl JU; Nuebling T; Wild J; Kroell T; Kanz L; Salih HR; Schmetzer H
J Investig Med; 2016 Dec; 64(8):1252-1260. PubMed ID: 27388616
[TBL] [Abstract][Full Text] [Related]
11. CD137 ligand signalling induces differentiation of primary acute myeloid leukaemia cells.
Cheng K; Wong SC; Linn YC; Ho LP; Chng WJ; Schwarz H
Br J Haematol; 2014 Apr; 165(1):134-44. PubMed ID: 24428589
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia.
Aureli A; Marziani B; Sconocchia T; Del Principe MI; Buzzatti E; Pasqualone G; Venditti A; Sconocchia G
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944865
[TBL] [Abstract][Full Text] [Related]
13. 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies.
Xu Y; Liu Q; Zhong M; Wang Z; Chen Z; Zhang Y; Xing H; Tian Z; Tang K; Liao X; Rao Q; Wang M; Wang J
J Hematol Oncol; 2019 May; 12(1):49. PubMed ID: 31097020
[TBL] [Abstract][Full Text] [Related]
14. Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia.
Van Acker HH; Versteven M; Lichtenegger FS; Roex G; Campillo-Davo D; Lion E; Subklewe M; Van Tendeloo VF; Berneman ZN; Anguille S
J Clin Med; 2019 Apr; 8(5):. PubMed ID: 31035598
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemia.
Kerage D; Soon MSF; Doff BL; Kobayashi T; Nissen MD; Lam PY; Leggatt GR; Mattarollo SR
Oncoimmunology; 2018; 7(10):e1486952. PubMed ID: 30288351
[TBL] [Abstract][Full Text] [Related]
16. The characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseases.
Yuan C; Song G; Jiang G
Intractable Rare Dis Res; 2012 May; 1(2):53-65. PubMed ID: 25343074
[TBL] [Abstract][Full Text] [Related]
17. The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses.
Barao I
Front Immunol; 2012; 3():402. PubMed ID: 23316193
[TBL] [Abstract][Full Text] [Related]
18. Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene.
Casucci M; Perna SK; Falcone L; Camisa B; Magnani Z; Bernardi M; Crotta A; Tresoldi C; Fleischhauer K; Ponzoni M; Gregori S; Caligaris Cappio F; Ciceri F; Bordignon C; Cignetti A; Bondanza A; Bonini C
Mol Ther; 2013 Feb; 21(2):466-75. PubMed ID: 23299798
[TBL] [Abstract][Full Text] [Related]
19. Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines.
Koido S; Homma S; Takahara A; Namiki Y; Komita H; Nagasaki E; Ito M; Nagatsuma K; Uchiyama K; Satoh K; Ohkusa T; Gong J; Tajiri H
J Biomed Biotechnol; 2011; 2011():910836. PubMed ID: 21541197
[TBL] [Abstract][Full Text] [Related]
20. Fc-dependent expression of CD137 on human NK cells: insights into "agonistic" effects of anti-CD137 monoclonal antibodies.
Lin W; Voskens CJ; Zhang X; Schindler DG; Wood A; Burch E; Wei Y; Chen L; Tian G; Tamada K; Wang LX; Schulze DH; Mann D; Strome SE
Blood; 2008 Aug; 112(3):699-707. PubMed ID: 18519814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
